Bio Product Guide » Genentech http://www.bioproductguide.com/blog A comprehensive guide to bio products for medical professionals Fri, 11 Jun 2010 08:56:43 +0000 http://wordpress.org/?v=2.8.2 en hourly 1 FDA Approves ACTEMRA(R) (tocilizumab) For The Treatment Of Moderately To Severely Active Rheumatoid Arthritis http://www.bioproductguide.com/blog/2010/01/12/fda-approves-actemrar-tocilizumab-for-the-treatment-of-moderately-to-severely-active-rheumatoid-arthritis/ http://www.bioproductguide.com/blog/2010/01/12/fda-approves-actemrar-tocilizumab-for-the-treatment-of-moderately-to-severely-active-rheumatoid-arthritis/#comments Tue, 12 Jan 2010 06:19:46 +0000 Jim Marino http://www.bioproductguide.com/blog/?p=221 Genentech, IncGenentech, Inc. has announced that the U.S. Food and Drug Administration (FDA) approved ACTEMRA® (tocilizumab) for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to one or more tumor necrosis factor (TNF) antagonist therapies. ACTEMRA is the first interleukin-6 (IL-6) receptor-inhibiting monoclonal antibody approved to treat RA, and may be used alone or in combination with methotrexate or other disease modifying anti-rheumatic drugs.

For the full story, Click Here

]]> http://www.bioproductguide.com/blog/2010/01/12/fda-approves-actemrar-tocilizumab-for-the-treatment-of-moderately-to-severely-active-rheumatoid-arthritis/feed/ 0